Diabetes Drugs

Brand Name: Erlina

Generic Name: Empagliflozin and Linagliptin

Dosage Strength: 25mg Empagliflozin and 5mg Linagliptin

Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.

Packing: 14 Tablets

Description and Usage:

Erlina is a medication brand that typically contains a combination of two active ingredients: Empagliflozin and Linagliptin, in 25/5mg tablet form. Empagliflozin belongs to the class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors, while Linagliptin belongs to the class of medications known as dipeptidyl peptidase-4 (DPP-4) inhibitors.

The combination of Empagliflozin and Linagliptin in Erlina tablets provides complementary mechanisms of action to help improve glycemic control in patients with type 2 diabetes mellitus. Empagliflozin works by promoting the excretion of excess glucose in the urine, while Linagliptin works by increasing insulin secretion and decreasing glucagon release from the pancreas.

Brand Name: Evopride

Generic Name: Glimepiride

Dosage Strength: 2mg

Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.

Packing: 30 Tablets

Description and Usage:

Evopride (Glimepiride) 2mg Tablets contain the active ingredient Glimepiride, which belongs to the class of sulfonylurea antidiabetic medications. Glimepiride works by stimulating the release of insulin from the pancreas, which helps lower blood sugar levels in patients with type 2 diabetes mellitus.

• Evopride (Glimepiride) 2mg Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
• It is typically prescribed when lifestyle modifications alone have not provided adequate blood sugar control.

Brand Name: Evopride Plus

Generic Name: Glimepiride + Metformin HCl

Dosage Strength: 1mg Glimepiride + 500mg Metformin HCl

Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.

Packing: 30 Tablets

Description and Usage:

Evopride Plus (Glimepiride + Metformin HCl) 1mg/500mg Tablets are a combination medication containing two active ingredients: Glimepiride, a sulfonylurea antidiabetic agent, and Metformin Hydrochloride, a biguanide antidiabetic agent. This combination is used to treat type 2 diabetes mellitus by helping to control blood sugar levels through different mechanisms of action.

• Evopride Plus (Glimepiride + Metformin HCl) 1mg/500mg Tablets are indicated for the management of type 2 diabetes mellitus in adults.
• This combination medication is typically prescribed when treatment with either Glimepiride or Metformin alone has not provided adequate blood sugar control.

Brand Name: Galvecta Plus

Generic Name: Vildagliptin + Metformin HCl

Dosage Strength: 50mg Vildagliptin + 500mg Metformin HCl

Manufacturer: Pharmaceutical (Pvt) Ltd.

Packing: 14 Tablets

Description and Usage:

Galvecta Plus (Vildagliptin+Metformin HCl) 50/500mg Tablets are indicated for the management of type 2 diabetes mellitus in adults. This combination medication helps to control blood sugar levels by multiple mechanisms of action.

• Vildagliptin: Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the enzyme DPP-4, which in turn increases the levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones stimulate insulin release from pancreatic beta cells and decrease glucagon secretion from pancreatic alpha cells, thereby reducing blood glucose levels.
• Metformin Hydrochloride: Metformin is a biguanide medication that works primarily by decreasing hepatic glucose production and increasing peripheral glucose uptake and utilization. It also improves insulin sensitivity in peripheral tissues such as muscle and adipose tissue.